NEUROSENSE THERAPEUTICS LTD. |
Market Closed -
Other stock markets
|
Pre-market 09:00:45 am | |||
| 1.27 USD | -4.51% |
|
1.205 | -5.12% |
Chart calendar NeuroSense Therapeutics Ltd.
5d1b742c2e8011b4d396249873c8ce.PVpjhEkM_4K5t0NFDpHTrL_gx8JBb0oFsnxNcQvlz7Y.Dw8AxSFbkrWP1C8iYLyngfqV6qAWJDow0CYHLmaR-t10DBLoBG2tzdffEg~f8805286d4673cf67950ee9d18215a04
Upcoming events on NeuroSense Therapeutics Ltd.
Past events on NeuroSense Therapeutics Ltd.
| 2024-04-16 07:30 pm | American Academy of Neurology Meeting |
| 2024-04-05 09:29 am | Q4 2023 Earnings Release |
| 2024-03-19 02:00 pm | Roth Conference |
| 2023-12-05 | ALS MND International Symposium |
| 2023-12-05 08:30 am | Amyotrophic Lateral Sclerosis Phase IIb Trial Call |
| 2023-11-28 08:45 am | Q3 2023 Earnings Release |
| 2023-11-15 | ALS ONE ALS Research Symposium |
| 2023-11-10 | Neuroscience Conference |
| 2023-11-05 | BIO Europe Fall Partnering Conference |
| 2023-10-03 | Emerging Growth Conference |
| 2023-10-03 | Northeast Amyotrophic Lateral Sclerosis Meeting |
| 2023-09-14 | Treatment and Research in ALS International Pan-Asian Consortium |
| 2023-09-12 08:30 am | Business Update Call |
| 2023-09-12 12:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-29 | Q2 2023 Earnings Release (Projected) |
| 2023-07-24 08:30 am | Business Update Call |
| 2023-07-22 | EverythingALS Digital Biomarkers Summit |
| 2023-07-11 | ENCALS Conference |
| 2023-06-21 09:00 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-01 08:45 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -5,59 -6,54 14.62% | -13,6 -13,5 -0.69% | -13,3 -13,1 -1.72% | -14,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -4,04 -6,53 38.15% | -12,3 -12,5 1.63% | -11,3 -11,5 1.51% | -13,9 |
|
Net income Million USD | Released Forecast Spread | -2,83 | -4,04 -6,32 36.07% | -12,3 -12,5 1.63% | -11,3 -11,4 1.2% | -14,1 |
|
EPS USD | Released Forecast Spread | -1,54 | -0,65 -0,84 22.62% | -1,07 -1,10 2.73% | -0,83 -0,82 -1.22% | -0,83 |
| Announcement Date | 10/08/21 | 14/04/22 | 22/03/23 | 05/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -1,26 -1,80 29.92% | -3,26 -2,04 -60.08% | -3,59 -3,30 -8.89% | -3,32 -3,65 8.94% | -3,38 -3,29 -2.83% | -3,64 -3,41 -6.68% | -3,48 -3,75 7.28% | -2,90 -3,65 20.63% | -3,29 -3,06 -7.37% | -3,19 | -3,30 | -3,57 | -3,85 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,99 -1,80 44.99% | -2,72 -2,04 -33.15% | -3,48 -3,30 -5.58% | -2,99 -3,65 17.86% | -3,15 -3,29 4.14% | -3,89 -3,41 -13.95% | 0,78 -3,55 122.08% | -2,95 -3,12 5.54% | -3,19 | -3,30 | -3,57 | -3,85 | |
|
Net income Million USD | Released Forecast Spread | -0,99 -1,80 44.99% | -2,72 -2,04 -33.15% | -3,48 -3,30 -5.58% | -2,99 -3,65 17.86% | -3,15 -3,29 4.14% | -3,89 -3,41 -13.95% | -5,23 -3,80 -37.5% | 0,78 -3,68 121.33% | -2,95 -3,09 4.42% | -3,19 | -3,30 | -3,57 | -3,85 |
|
EPS USD | Released Forecast Spread | -0,07 -0,16 56.25% | -0,24 -0,18 -33.33% | -0,31 -0,28 -10.71% | -0,25 -0,28 10.71% | -0,27 -0,28 3.57% | -0,33 -0,29 -13.79% | -0,44 -0,28 -57.14% | 0,10 -0,26 138.46% | -0,16 -0,20 20% | -0,20 | -0,21 | -0,20 | -0,22 |
| Announcement Date | 14/04/22 | 31/05/22 | 31/08/22 | 01/12/22 | 22/03/23 | 01/06/23 | 16/08/23 | 28/11/23 | 05/04/24 | - | - | - | - |
| Today 04:01 pm | HALOZYME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | RAPT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | 89BIO, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | DYNAVAX TECHNOLOGIES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 | BEIGENE, LTD.: Q1 2024 Earnings Release |
| 2024-05-08 04:00 pm | MANNKIND CORPORATION: Q1 2024 Earnings Release |
| 2024-05-08 04:00 pm | CYTOKINETICS, INCORPORATED: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | PROTHENA CORPORATION PLC: Q1 2024 Earnings Release |
Past sector events for NeuroSense Therapeutics Ltd.
| Today 07:00 am | RHYTHM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 07:00 am | MADRIGAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today | COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| Today | Y-MABS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today | INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release (Projected) |
| Today | PHILOGEN S.P.A.: Q1 2024 Earnings Release |
| 2024-05-06 04:05 pm | ORIC PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 04:01 pm | ROCKET PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 04:01 pm | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| 2024-05-06 08:00 am | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NRSN Stock
- Calendar NeuroSense Therapeutics Ltd.